A new paper has emerged entitled
Clinical debate: subclinical hypothyroidism
Jasim S, Abdi H, Gharib H, Biondi B. A
Int J Endocrinol Metab. 2021;19(3):e115948. doi: 10.5812/ijem.115948.
In this is a debate about treatment or not in two cases discussed in detail. It's interesting that it shows up the logic or lack of it in reaching a decision in this difficult situation. It still however categorises patient groups via statistical TSH ranges i.e. subclinical has a range of about 5-9 TSH. It still falls into the error of thinking one can so neatly box a patient into a TSH-based decision process. But it's worth a read to see how decisions are made in this field.